Onswik (Insulin Efsitora Alfa)

Onswik is a long-acting insulin for adults with type 2 diabetes. It is a shot under the skin given just once a week from a prefilled pen. It works like the body's own background insulin, helping move sugar out of the blood all week long.

Brand names:Onswik
Medication

What people taking Onswik (Insulin Efsitora Alfa) report

Every report comes from a Lived member, sent anonymously.

Have you tried Onswik (Insulin Efsitora Alfa) for Type 2 Diabetes?

NameHow it went

About Onswik (Insulin Efsitora Alfa)

What It's For

Insulin efsitora alfa, sold as Onswik, is a long-acting insulin injected once a week. The FDA approved it in 2026 for adults with type 2 diabetes, used along with diet and exercise to lower blood sugar and keep it steadier. Its full name on the label is insulin efsitora alfa-gobe. It serves as a basal, or background, insulin: the steady low level of insulin the body needs between meals and overnight. It can be a first insulin for someone whose blood sugar is no longer controlled on pills or other non-insulin medicines, or it can replace a daily basal insulin such as insulin glargine or insulin degludec. It can be combined with metformin, GLP-1 medicines and other diabetes treatments, and with mealtime insulin. It is not recommended for type 1 diabetes. In a year-long study of adults with type 1 diabetes, severe low blood sugar happened more often than with a daily insulin (10% of people versus 3%). It is not known whether it is safe and effective in children.

How It Works

Insulin is the hormone that lets muscle and fat cells take sugar out of the blood and tells the liver to stop releasing more. In type 2 diabetes, the body does not make enough insulin or does not respond to it well, so sugar builds up in the blood. A background insulin fills part of that gap around the clock. Efsitora is a lab-made insulin joined to the Fc region, a stable tail section of a human antibody. That attachment makes the molecule too large for the kidneys to clear quickly and lets it use the same recycling system that keeps antibodies in the blood for weeks. It also binds the insulin receptor more loosely than human insulin, so it is used up slowly. The result is an effect that stays nearly flat across the week, strongest around days 4 and 5 but only slightly higher than at its lowest point. Once it reaches the insulin receptor, it acts the same way the body's own insulin does.

Dosage & Administration

Onswik comes in two prefilled pens, called KwikPens: a U-500 pen that dials in 5-unit steps and a U-1,000 pen that dials in 10-unit steps. The numbers look large next to daily insulin doses because each injection covers a whole week. It is injected under the skin of the abdomen, thigh, upper arm or buttocks once a week on the same day. The day can be changed as long as at least 4 days have passed since the last dose. Rotating spots within the same area helps prevent lumpy or thickened skin, which can make insulin absorb unpredictably. It is not used in an insulin pump or mixed with other insulins. People new to insulin either start at a fixed weekly dose that is raised in steps every few weeks, or take a larger one-time first dose followed by a lower weekly dose adjusted from there. People switching from a daily basal insulin take their first Onswik dose the day after their last daily dose, often as a one-time starting dose calculated from their previous daily amount. The starting dose is given only once; repeating it is a known cause of serious low blood sugar. Weekly insulin has led to hospital stays for severe lows when it was confused with another insulin or another weekly diabetes injection, when the wrong number was dialed, or when it was injected too often. Check the pen label before each injection and confirm the number in the dose window. Never draw insulin out of the pen with a syringe, because syringe markings will not measure this insulin correctly. Never share a pen with anyone, even with a new needle, because it can spread blood-borne infections. If a dose is missed, take it within 4 days and keep the usual day. If more than 4 days have passed, either skip it and take the next dose on the usual day, or take it and make that the new weekly day. If a weekly dose or the starting dose was taken twice, skip the next week's dose and check blood sugar more often. Unopened pens are kept in the refrigerator. Once in use, a pen is good for up to 16 weeks, with no more than 14 days in total out of the refrigerator.

Side Effects

Low blood sugar (hypoglycemia) is the most common side effect, as with any insulin. For many people with diabetes, low means a reading below 70 mg/dL. Signs include shakiness, sweating, hunger, a fast heartbeat, headache, dizziness, irritability, confusion and blurred vision. The usual first step is fast-acting sugar, such as glucose tablets or juice, followed by a recheck. Because Onswik keeps working for weeks, a low can take longer to resolve than with a daily insulin and can return after it seems to have passed, so keep eating carbohydrates and keep checking. Lows that keep happening are a reason to call the care team promptly rather than wait for the next dose. Severe low blood sugar, when someone is too confused to treat themselves, cannot swallow safely, passes out or has a seizure, is an emergency: someone nearby should give glucagon if it is available and call 911. Weight gain is common with insulin. In the studies, people gained an average of about 2 to 4 kg (roughly 5 to 9 pounds) over a year. Some people notice redness, itching or swelling where they inject, mild swelling of the ankles and feet, or itchy rashes. A fast improvement in blood sugar after starting insulin can briefly blur vision and has been linked to worsening diabetic eye disease or a flare of nerve pain, which is worth mentioning at eye and foot checks. Severe allergic reactions are rare. Trouble breathing, a fast heartbeat with swelling of the face, tongue or throat, or a rash over the whole body needs emergency help: stop using Onswik and call 911.

Interactions & Warnings

Many medicines shift blood sugar, so the prescriber and pharmacist should see a full list, including supplements. Other diabetes medicines, such as GLP-1 medicines and SGLT2 inhibitors, add to the chance of lows and may mean a lower insulin dose. Steroids such as prednisone, some antipsychotics, certain diuretics and thyroid hormone can push blood sugar up. Beta-blockers, common heart and blood pressure medicines, can hide the shakiness and fast heartbeat that signal a low, so meter or sensor readings matter more than symptoms. Alcohol can also cause lows, and the label advises avoiding it. Two combinations deserve particular attention. Pioglitazone, a diabetes pill in the TZD (thiazolidinedione) class, can cause fluid retention when taken with insulin and can lead to or worsen heart failure; new shortness of breath, sudden weight gain or swelling of the ankles or feet should be reported to the prescriber. FcRn inhibitors, such as efgartigimod (Vyvgart), used for generalized myasthenia gravis, can make Onswik less effective because they block the recycling system it depends on. A different basal insulin may be a better choice for someone who needs one of these medicines. Onswik should not be injected during a low. Use during pregnancy or breastfeeding is not recommended: human data are too limited, and in animal studies the drug reached the fetus and nursing young and caused harm linked to low blood sugar. Anyone pregnant or planning a pregnancy should talk with the prescriber about an insulin with an established pregnancy record. Older adults and people with kidney or liver disease may be more prone to lows, so doses are raised cautiously and glucose is checked more often.

What to Expect

Onswik changes blood sugar slowly. After it is started or the dose changes, fasting readings usually begin to move within 1 to 2 weeks, and the full effect of that change takes about 4 weeks. That is why doses are adjusted gradually, often in steps of 20 to 40 units a week based on fasting readings, and why the dose is not usually changed for a short illness or a few days of different eating or activity; those are handled with food, other medicines or extra checking. People switching from a daily insulin who leave out the one-time starting dose may see higher readings for 4 to 6 weeks before they settle. In the main studies, adults new to insulin saw their HbA1c (a blood test reflecting average blood sugar over about three months) fall by about 1.2 percentage points over a year, matching daily insulin glargine or insulin degludec. People switching from a daily basal insulin kept similar control. The main practical difference is one injection a week instead of seven. Expect more frequent glucose checks, by fingerstick or a continuous glucose monitor, while starting and adjusting the dose, then regular HbA1c tests and routine diabetes care. Insulin for type 2 diabetes is usually long term. If Onswik is stopped, its effect fades over about 4 to 6 weeks, so switching to another insulin needs a plan from the prescriber. If blood sugar does not improve despite rising doses, the prescriber may suggest a different insulin.

Questions to Ask Your Doctor

  1. 1.Is a once-weekly insulin a good fit for me compared with a daily basal insulin, and what would change in my routine?
  2. 2.Which pen and starting approach will I use, and how do I avoid repeating the starting dose or mixing it up with my other injections?
  3. 3.What fasting blood sugar range are we aiming for, and how often should I check while my dose is being adjusted?
  4. 4.Because this insulin lasts for weeks, how should I handle a low, and when should I call you about one?
  5. 5.Do any of my other medicines need to change, and what would we do if I became pregnant?

Last reviewed • Oct 2026

Educational content, not medical advice.